Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
3
75%
Ph phase_3
1
25%

Phase Distribution

0

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
3(75.0%)
Phase 3Large-scale testing
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Other(2)

Detailed Status

unknown2
Completed1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 23 (75.0%)
Phase 31 (25.0%)

Trials by Status

unknown250%
completed125%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingphase_2

TCM Formula vs. HMB in Pre-Frail Elders: Muscle Strength and Bone Status

NCT07597850
unknownphase_2

RSYR for Fatigue Reduction in Cancer Fatigue Caused by Chemotherapy

NCT05229029
completedphase_3

Prophylactic TCM for Mitigation of EGFR-TKI Related Dermatological Adverse Effect

NCT05204758
unknownphase_2

Effect of Traditional Chinese Medicine on Basic Tear Secretion and Tear Cytokines in Patients With Dry Eye Disease

NCT04785261

Clinical Trials (4)

Showing 4 of 4 trials
NCT07597850Phase 2

TCM Formula vs. HMB in Pre-Frail Elders: Muscle Strength and Bone Status

Recruiting
NCT05229029Phase 2

RSYR for Fatigue Reduction in Cancer Fatigue Caused by Chemotherapy

Unknown
NCT05204758Phase 3

Prophylactic TCM for Mitigation of EGFR-TKI Related Dermatological Adverse Effect

Completed
NCT04785261Phase 2

Effect of Traditional Chinese Medicine on Basic Tear Secretion and Tear Cytokines in Patients With Dry Eye Disease

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4